Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Urinary Tract Infections
Interventions
DRUG

Amikacin

patient will be treated with amikacin 15 mg/kg IV or IM, based on actual body weight; for patients \>120% of IBW, we will use AdjBW (IBW + 0.4(ABW-IBW)) rounded to nearest 50 mg. Patients who already have an IV will receive the medication IV, otherwise the dose will be given IM.

Trial Locations (1)

11219

RECRUITING

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER